Groundbreaking research shows psilocybin therapy equals traditional antidepressants in treating depression with potential ...
Depression speeds up physical illness. A study shows adults with depression develop conditions 30% faster. Read more.
Psilocybin therapy significantly decreased moderate to severe symptoms of depression in clinicians after frontline work ...
Supernus Pharmaceuticals may have had a potential path forward for its depression drug candidate cut off after the asset ...
However, some believe ECT affects neurotransmitters, hormones, brain structure, and cell regeneration, contributing to an improvement in depression. Learn more about ECT. During shock therapy ...
Depression is not just a mental health issue it’s a condition that affects the entire body and can accelerate the onset of ...
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) revealed the topline data from the Phase 2b study of SPN-820 in adults with ...
Creatine supplementation could lead to a faster reduction in depressive symptoms compared to traditional antidepressants,' ...
Exercise isn't a cure for depression, but it can encourage the release of hormones that help lift your mood. It can also boost your self-confidence and help you sleep better. (Photo Credit: Moment ...
Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...
After SPN-820's failure, Supernus is relying on its non-stimulant ADHD drug Qelbree and the recently approved Parkinson’s ...